QA: Theriva Biologics Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000894158_2022_Theriva_Biologics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000894158, Theriva Biologics Inc

  xvar xval
0 AssetsCurrent 68,858,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 101,000
3 remainder_Assets 1,406,000
4 LiabilitiesCurrent 3,554,000
5 LiabilitiesNoncurrent 1,403,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,144,180
9 ResearchAndDevelopmentExpense 9,560,911
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 11,391
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 70,365,000
1 Liabilities 4,957,000
2 Expenses 16,705,091
3 Revenues 0
4 StockholdersEquity 65,408,000
5 NetIncome -16,693,700
6 ComprehensiveNetIncome -16,693,700
7 BaseVar 46,019,241
8 EconomicCapitalRatiobeforeLimitedLiability 3.34
9 EconomicCapitalRatio 3.92

Edgar->Model Mapping

Feature Distribution

Change over Time